Author

William M Chasanov

Observed names: WM Chasanov, William Chasanov

Institutions: Beebe Healthcare, Beebe Healthcare

Observed institutions: Cooper University Hospital, Beebe Healthcare, Beebe Healthcare

OpenAlex ID: A5032400768

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

2018 · Alejandro Arenas-Pinto, Birgit Grund, et al. · Clinical Infectious Diseases · 26

An Update on HIV-1 Protease Inhibitor Resistance

2016 · John D Baxter, William M Chasanov · Journal of AIDS & Clinical Research · 13

Statewide Antibiotic Stewardship:

2019 · Marci Drees, Kimberly Fischer, et al. · Delaware Journal of Public Health · 4

Tricuspid Valve Endocarditis Partly Due to a Penicillin Susceptible, Ceftriaxone-Resistant Streptococcus anginosus Isolate

2017 · Lucia Rose, William Chasanov, et al. · American Journal of Therapeutics · 4

HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa

2016 · Adam J. Ericsen, Michael Lauck, et al. · 1

923. Providers’ Perception of CME Antimicrobial Stewardship Quizzes and Its Impact on Antibiotic Prescribing Practices

2022 · Shannon Chan, Nicole Harrington, et al. · Open Forum Infectious Diseases

Increased risk of suicidal behaviour with use of efavirenz: results from the START trial

2016 · Alejandro Arenas‐Pinto, Birgit Grund, et al. · UCL Discovery (University College London)

Works count: 7

Citation count: 48

H-index: 4

I10-index: 2